Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Big Books & Bold Ideas with Kerri Miller
Kerri Miller and Kelly Gordon

Would you take a test that could predict your risk of Alzheimer’s disease?

Two hands clasped together.
A nurse holds the hands of a person suffering from Alzheimer's disease on September 21, 2009 at a retirement home in France.
Sebastien Bozon | AFP via Getty Images

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

You probably know someone living with Alzheimer’s or dementia. More than 5.8 million Americans have the disease, and 1 out of every 3 seniors has Alzheimer’s or dementia at death.

Researchers are fast developing ways to diagnose the illness years before symptoms start: blood tests, retinal scans, brain scans. But if a reliable test was put on the market, would you take it? How much information about your medical future would you want, especially when it comes to a disease that currently has no cure? Wednesday on MPR News with Kerri Miller, we spoke with an Alzheimer’s researcher and a psychologist specializing in dementia issues about the moral dilemmas raised by medical developments.

Guests:

  • Dr. Peter Rabins, professor emeritus of psychiatry and medicine at John Hopkins University School of Medicine, author of the best-selling “The 36-Hour Day” and the upcoming “Is It Alzheimer’s?”

  • Shana Stites, clinical psychologist and researcher with the Penn Project on Precision Medicine for the Brain

To listen to the full conversation you can use the audio player above.

Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS